No One Is the Same: Medicine That Adapts to You

The device on your wrist right now can already tell you more about how your body is responding, minute to minute, than most clinical visits capture in a year. Heart rate variability, sleep architecture, activity load, even early signals of physiological stress — continuously measured, continuously available. What's largely missing isn't the data. It's a system built to treat that stream of response as something a treatment plan should actually respond to, rather than something collected and reviewed only at the next scheduled appointment.

Why "one dose fits all" was always a simplification

A standard dose, calculated against a population average and adjusted at most for body weight, has always been a simplification — a reasonable one, given the tools available, but a simplification nonetheless. Two people can receive an identical intervention and metabolize it differently, respond to it differently, and tolerate it differently, for reasons that a single static number was never going to capture. The gap between the average response and any individual's actual response is exactly where a meaningful amount of real-world variability in outcomes tends to live.

Continuous biosensing doesn't eliminate that gap by itself. What it does is make the gap visible in something closer to real time, rather than retrospectively, at the next visit, after the mismatch has already had weeks to compound.

What "adaptive" should mean — and what it shouldn't

We think it's worth being precise here, because "adaptive medicine" can sound like a promise of autonomous, always-on dose adjustment happening quietly in the background, and that's not what we mean and not what we think is responsible. The vision we're building toward keeps a clinician firmly in the loop: continuous signal informs a recommendation, and any actual change happens inside boundaries a prescriber has authorized in advance — never as a fully autonomous decision a device makes on its own. Bounded, reviewed, and escalated to a human whenever a signal falls outside the range that's already been agreed on. That's a meaningfully different claim than "your wearable adjusts your medication," and it's the one we're actually making.

Where this connects to everything else we're building

This is the same underlying thesis as bespoke therapeutics and digital twins, viewed from a different angle: individual biological response, tracked continuously and reasoned about explicitly, is more informative than a population average captured once. Continuous biosensing is the input side of that thesis — the stream of real signal that keeps an individualized model honest, rather than letting it drift into an assumption that was only ever true on average.

We're not there yet, and we don't think anyone credibly is. But the components — wearable sensing that's already good enough to be useful, and reasoning architecture built to hold individual context instead of collapsing it — are closer to existing together than they've ever been. That convergence is what this piece is actually about.